Jul 12, 2020 1:48 PM
BACK TO TOP
KSE100
36,190.40
48.23
(0.13%)
ALLSHR
25,841.82
26.53
(0.10%)
KSE30
15,693.71
17.94
(0.11%)
KMI30
57,654.37
56.51
(0.10%)
BKTi
10,952.95
11.49
(0.11%)
OGTi
13,670.32
-97.10
(-0.71%)
KMIALLSHR
17,951.42
4.66
(0.03%)
UPP9
10,621.54
26.01
(0.25%)
NITPGI
8,130.70
0.14
(0.00%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.619.46
-12.21
(-1.93%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jul 10, 2020 1:32 PM
REG
FUT
ODL
Open
625.90
High
633.00
Low
617.25
Volume
13,000
CIRCUIT BREAKER
584.29 — 679.05
DAY RANGE
617.25 — 633.00
52-WEEK RANGE
302.10 — 674.99
Ask Price
619.46
Ask Volume
100
Bid Price
0.00
Bid Volume
0
LDCP
631.67
VAR
15.50
HAIRCUT
22.50
P/E Ratio (TTM)
33.06
1-Year Change *
42.73%
YTD Change *
38.65%
Open
625.00
High
625.00
Low
625.00
Close
625.00
Change
-1.06%
LDCP
631.67
Volume
20
Total Trades
2
CIRCUIT BREAKER
568.50 — 694.84
DAY RANGE
625.00 — 625.00
Ask Price
639.00
Ask Volume
26
Bid Price
618.00
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited (the Company) is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of research based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Munir A. ShaikhChairman
Mr. Syed Anis AhmedCEO
Mr. Humayun AltafCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
60,645,321.08
Shares
97,900,302
Free Float
21,028,827
Free Float
21.48%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Jun 1, 2020Transmission of Quarterly Report period ended View   PDF
Jun 1, 2020Financial Results for the 1st Quarter View   PDF
May 29, 2020Quarterly Report for the period ended March 31st, 2020 View   PDF
May 29, 2020Financial Result for the 1st Quarter View   PDF
Apr 8, 2020Grant of Extension for filing Financial Statements for the First Quarter ended on 31 March 2020 View   PDF
Apr 6, 2020Extension for filing Financial Statements for the First Quarter ended on 31 March 2020 View   PDF
Mar 27, 2020Transmission of Annual Report for the Year ended December 31st,2019 View   PDF
Mar 2, 2020Financial Results for the year ended 2019-12-31 View   PDF
Oct 17, 2019Financial Results For The 3rd Quarter View   PDF
Aug 16, 2019Financial Results for the Quarter ended June 30, 2019 View   PDF
DateTitleDocument
May 28, 2020Board Meeting in Progress View   
May 21, 2020Board Meeting View   
May 5, 2020Notice of Annual General Meeting View   PDF
Mar 18, 2020Notice of Annual General Meeting View   PDF
Feb 24, 2020Board Meeting View   
Oct 10, 2019Board Meeting View   
Aug 9, 2019Board Meeting View   
Apr 16, 2019Board Meeting View   
Mar 20, 2019Notice of Annual General Meeting View   PDF
Feb 14, 2019Board of Directors Meeting View   
DateTitleDocument
Jun 11, 2020Dispatch of Final Dividend Warrants View   
May 29, 2020Re-Appointment of Chief Executive View   PDF
May 29, 2020Re-Appointment of Chairman View   PDF
May 28, 2020Election of Directors View   PDF
May 20, 2020Notice Election of Directors View   PDF
May 13, 2020Addendum to AGM Notice View   PDF
Apr 3, 2020Postponement of the 71st AGM of Abbott Laboratories (Pakistan) Limited View   PDF
Mar 30, 2020Dissemination of the Annual Report of Abbott Laboratories Pakistan Limited View   PDF
Jan 17, 2020Appointment of Company Secretary View   PDF
Jan 17, 2020Change of Company Secretary View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales30,155,87529,719,27926,088,23323,387,915
Profit after Taxation1,299,8852,694,3334,205,2324,021,792
EPS13.2827.5242.9541.08
Q1 2020Q3 2019Q2 2019Q1 2019
Sales8,061,4936,974,8318,089,7237,215,799
Profit after Taxation862,517265,791178,777327,669
EPS8.812.711.833.35
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)28.2832.8938.6740.05
Net Profit Margin (%)4.319.0716.1217.20
EPS Growth (%)(51.74)(35.93)4.5512.12
PEG(0.66)(0.64)3.571.92

Payouts

DateFinancial ResultsDetailsBook Closure
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 20/05/2020 - 27/05/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017
August 19, 2016 3:32 PM30/06/2016(HYR) 100% (D) 06/09/2016 - 16/09/2016
February 19, 2016 4:19 PM31/12/2015(YR) 200% (D) 14/04/2016 - 21/04/2016
August 17, 2015 1:36 PM30/06/2015(HYR) 100% (D) 04/09/2015 - 11/09/2015
February 24, 2015 1:46 PM31/12/2014(YR) 48% (D) 16/04/2014 - 23/04/2014

Financial Reports